Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Dec 17, 2012 mccorkle douglas s Officer Automatic Sell 1,000 178.19 - 179.45
Jan 14, 2011 roberts william Officer Option Execute 1,188 9.49
Dec 18, 2012 aberman michael s Officer Option Execute 1,200 24.00
Jan 12, 2011 vagelos p roy Officer Disposition (Non Open Market) 1,203 n/a
Jan 12, 2011 vagelos p roy Officer Acquisition (Non Open Market) 1,203 n/a
Apr 4, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,215 n/a
Jan 8, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,254 n/a
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Jan 2, 2009 goldberg murray a Officer Option Execute 1,300 7.41
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Oct 9, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,392 n/a
Jan 19, 2011 roberts william Officer Automatic Sell 1,399 34.61 - 35.42
Dec 17, 2007 gilman alfred g Director Disposition (Non Open Market) 1,500 n/a
Feb 3, 2010 roberts william Officer Option Execute 1,500 13.00
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Showing 41-60 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)